{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:16:00Z","timestamp":1790057760708,"version":"4.0.1"},"reference-count":220,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1007\/s00018-019-03174-6","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T15:03:21Z","timestamp":1559833401000},"page":"3097-3116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["MMPs and ADAMs in neurological infectious diseases and multiple sclerosis"],"prefix":"10.1007","volume":"76","author":[{"given":"Lukas","family":"Muri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Grandgirard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-6123","authenticated-orcid":false,"given":"Stephen L.","family":"Leib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"3174_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrn1807","volume":"6","author":"VW Yong","year":"2005","unstructured":"Yong VW (2005) Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 6:931\u2013944. https:\/\/doi.org\/10.1038\/nrn1807","journal-title":"Nat Rev Neurosci"},{"key":"3174_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463\u2013516. https:\/\/doi.org\/10.1146\/annurev.cellbio.17.1.463","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3174_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ceb.2004.07.010","volume":"16","author":"JD Mott","year":"2004","unstructured":"Mott JD, Werb Z (2004) Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16:558\u2013564. https:\/\/doi.org\/10.1016\/j.ceb.2004.07.010","journal-title":"Curr Opin Cell Biol"},{"key":"3174_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0955-0674(00)00248-9","volume":"13","author":"LJ McCawley","year":"2001","unstructured":"McCawley LJ, Matrisian LM (2001) Matrix metalloproteinases: they\u2019re not just for matrix anymore! Curr Opin Cell Biol 13:534\u2013540","journal-title":"Curr Opin Cell Biol"},{"key":"3174_CR5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nri1418","volume":"4","author":"WC Parks","year":"2004","unstructured":"Parks WC, Wilson CL, L\u00f3pez-Boado YS (2004) Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4:617\u2013629. https:\/\/doi.org\/10.1038\/nri1418","journal-title":"Nat Rev Immunol"},{"key":"3174_CR6","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ceb.2003.08.001","volume":"15","author":"JM White","year":"2003","unstructured":"White JM (2003) ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15:598\u2013606","journal-title":"Curr Opin Cell Biol"},{"key":"3174_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/35081571","volume":"2","author":"VW Yong","year":"2001","unstructured":"Yong VW, Power C, Forsyth P, Edwards DR (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502\u2013511. https:\/\/doi.org\/10.1038\/35081571","journal-title":"Nat Rev Neurosci"},{"key":"3174_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nrc884","volume":"2","author":"CM Overall","year":"2002","unstructured":"Overall CM, L\u00f3pez-Ot\u00edn C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657\u2013672. https:\/\/doi.org\/10.1038\/nrc884","journal-title":"Nat Rev Cancer"},{"key":"3174_CR9","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1073\/pnas.87.14.5578","volume":"87","author":"HE Van Wart","year":"1990","unstructured":"Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578\u20135582","journal-title":"Proc Natl Acad Sci USA"},{"key":"3174_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1126\/science.2982211","volume":"227","author":"SJ Weiss","year":"1985","unstructured":"Weiss SJ, Peppin G, Ortiz X et al (1985) Oxidative autoactivation of latent collagenase by human neutrophils. Science 227:747\u2013749","journal-title":"Science"},{"key":"3174_CR11","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1073\/pnas.83.12.4322","volume":"83","author":"GJ Peppin","year":"1986","unstructured":"Peppin GJ, Weiss SJ (1986) Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci USA 83:4322\u20134326","journal-title":"Proc Natl Acad Sci USA"},{"key":"3174_CR12","doi-asserted-by":"publisher","first-page":"41279","DOI":"10.1074\/jbc.M106958200","volume":"276","author":"X Fu","year":"2001","unstructured":"Fu X, Kassim SY, Parks WC, Heinecke JW (2001) Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276:41279\u201341287. https:\/\/doi.org\/10.1074\/jbc.M106958200","journal-title":"J Biol Chem"},{"key":"3174_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827\u2013839. https:\/\/doi.org\/10.1161\/01.RES.0000070112.80711.3D","journal-title":"Circ Res"},{"key":"3174_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1042\/bss0700065","volume":"70","author":"G Murphy","year":"2003","unstructured":"Murphy G, Kn\u00e4uper V, Lee M-H et al (2003) Role of TIMPs (tissue inhibitors of metalloproteinases) in pericellular proteolysis: the specificity is in the detail. Biochem Soc Symp 70:65\u201380","journal-title":"Biochem Soc Symp"},{"key":"3174_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nri3499","volume":"13","author":"R Khokha","year":"2013","unstructured":"Khokha R, Murthy A, Weiss A (2013) Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol 13:649\u2013665. https:\/\/doi.org\/10.1038\/nri3499","journal-title":"Nat Rev Immunol"},{"key":"3174_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1161\/01.STR.21.5.801","volume":"21","author":"GA Rosenberg","year":"1990","unstructured":"Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M (1990) Collagenase-induced intracerebral hemorrhage in rats. Stroke 21:801\u2013807","journal-title":"Stroke"},{"key":"3174_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0006-8993(92)90681-X","volume":"576","author":"GA Rosenberg","year":"1992","unstructured":"Rosenberg GA, Kornfeld M, Estrada E et al (1992) TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 576:203\u2013207. https:\/\/doi.org\/10.1016\/0006-8993(92)90681-X","journal-title":"Brain Res"},{"key":"3174_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/B978-0-444-63486-3.00014-1","volume":"214","author":"K Baranger","year":"2014","unstructured":"Baranger K, Rivera S, Liechti FD et al (2014) Endogenous and synthetic MMP inhibitors in CNS physiopathology. Prog Brain Res 214:313\u2013351","journal-title":"Prog Brain Res"},{"key":"3174_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0006-8993(95)01089-0","volume":"703","author":"GA Rosenberg","year":"1995","unstructured":"Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG (1995) Tumor necrosis factor-\u03b1-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res 703:151\u2013155. https:\/\/doi.org\/10.1016\/0006-8993(95)01089-0","journal-title":"Brain Res"},{"key":"3174_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0006-8993(02)02303-X","volume":"933","author":"S Mun-Bryce","year":"2002","unstructured":"Mun-Bryce S, Lukes A, Wallace J et al (2002) Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation. Brain Res 933:42\u201349","journal-title":"Brain Res"},{"key":"3174_CR21","first-page":"R1203","volume":"274","author":"S Mun-Bryce","year":"1998","unstructured":"Mun-Bryce S, Rosenberg GA (1998) Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 274:R1203\u2013R1211","journal-title":"Am J Physiol"},{"key":"3174_CR22","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fneur.2013.00032","volume":"4","author":"SE Lakhan","year":"2013","unstructured":"Lakhan SE, Kirchgessner A, Tepper D, Leonard A (2013) Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol 4:32. https:\/\/doi.org\/10.3389\/fneur.2013.00032","journal-title":"Front Neurol"},{"key":"3174_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.nbd.2005.09.007","volume":"21","author":"J Sellner","year":"2006","unstructured":"Sellner J, Leib SL (2006) In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9\/TIMP-1 ratio and increased collagen type IV degradation. Neurobiol Dis 21:647\u2013656. https:\/\/doi.org\/10.1016\/j.nbd.2005.09.007","journal-title":"Neurobiol Dis"},{"key":"3174_CR24","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1161\/01.STR.29.10.2189","volume":"29","author":"GA Rosenberg","year":"1998","unstructured":"Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29:2189\u20132195","journal-title":"Stroke"},{"key":"3174_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","volume":"27","author":"Y Yang","year":"2007","unstructured":"Yang Y, Estrada EY, Thompson JF et al (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27:697\u2013709. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600375","journal-title":"J Cereb Blood Flow Metab"},{"key":"3174_CR26","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/hep.23203","volume":"50","author":"F Chen","year":"2009","unstructured":"Chen F, Ohashi N, Li W et al (2009) Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology 50:1914\u20131923. https:\/\/doi.org\/10.1002\/hep.23203","journal-title":"Hepatology"},{"key":"3174_CR27","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1523\/JNEUROSCI.2674-08.2008","volume":"28","author":"BW McColl","year":"2008","unstructured":"McColl BW, Rothwell NJ, Allan SM (2008) Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci 28:9451\u20139462. https:\/\/doi.org\/10.1523\/JNEUROSCI.2674-08.2008","journal-title":"J Neurosci"},{"key":"3174_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/187152708784936608","volume":"7","author":"RM Adibhatla","year":"2008","unstructured":"Adibhatla RM, Hatcher JF (2008) Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord Drug Targets 7:243\u2013253","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3174_CR29","doi-asserted-by":"publisher","first-page":"H558","DOI":"10.1152\/ajpheart.01275.2004","volume":"289","author":"JM Gidday","year":"2005","unstructured":"Gidday JM, Gasche YG, Copin J-C et al (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Circ Physiol 289:H558\u2013H568. https:\/\/doi.org\/10.1152\/ajpheart.01275.2004","journal-title":"Am J Physiol Circ Physiol"},{"key":"3174_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1189\/jlb.1109766","volume":"87","author":"R Jin","year":"2010","unstructured":"Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87:779\u2013789. https:\/\/doi.org\/10.1189\/jlb.1109766","journal-title":"J Leukoc Biol"},{"key":"3174_CR31","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/01.WCB.0000090680.07515.C8","volume":"23","author":"C Justicia","year":"2003","unstructured":"Justicia C, Pan\u00e9s J, Sol\u00e9 S et al (2003) neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion\/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 23:1430\u20131440. https:\/\/doi.org\/10.1097\/01.WCB.0000090680.07515.C8","journal-title":"J Cereb Blood Flow Metab"},{"key":"3174_CR32","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1086\/374644","volume":"187","author":"DN Meli","year":"2003","unstructured":"Meli DN, Christen S, Leib SL (2003) Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. J Infect Dis 187:1411\u20131415. https:\/\/doi.org\/10.1086\/374644","journal-title":"J Infect Dis"},{"key":"3174_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S1471-4906(01)02023-3","volume":"22","author":"G Opdenakker","year":"2001","unstructured":"Opdenakker G, Van den Steen PE, Van Damme J (2001) Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 22:571\u2013579","journal-title":"Trends Immunol"},{"key":"3174_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1432-1033.1991.tb16027.x","volume":"198","author":"S Masure","year":"1991","unstructured":"Masure S, Proost P, Van Damme J, Opdenakker G (1991) Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur J Biochem 198:391\u2013398","journal-title":"Eur J Biochem"},{"key":"3174_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1086\/313922","volume":"31","author":"D Leppert","year":"2000","unstructured":"Leppert D, Leib SL, Grygar C et al (2000) Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis 31:80\u201384. https:\/\/doi.org\/10.1086\/313922","journal-title":"Clin Infect Dis"},{"key":"3174_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","volume":"41","author":"T Klein","year":"2011","unstructured":"Klein T, Bischoff R (2011) Physiology and pathophysiology of matrix metalloproteases. Amino Acids 41:271\u2013290. https:\/\/doi.org\/10.1007\/s00726-010-0689-x","journal-title":"Amino Acids"},{"key":"3174_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nbd.2006.02.006","volume":"23","author":"KJ Gurney","year":"2006","unstructured":"Gurney KJ, Estrada EY, Rosenberg GA (2006) Blood\u2013brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 23:87\u201396. https:\/\/doi.org\/10.1016\/j.nbd.2006.02.006","journal-title":"Neurobiol Dis"},{"key":"3174_CR38","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/hr.2009.26","volume":"32","author":"M Ueno","year":"2009","unstructured":"Ueno M, Wu B, Nishiyama A et al (2009) The expression of matrix metalloproteinase-13 is increased in vessels with blood\u2013brain barrier impairment in a stroke-prone hypertensive model. Hypertens Res 32:332\u2013338. https:\/\/doi.org\/10.1038\/hr.2009.26","journal-title":"Hypertens Res"},{"key":"3174_CR39","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1021\/pr801012x","volume":"8","author":"E Cuadrado","year":"2009","unstructured":"Cuadrado E, Rosell A, Penalba A et al (2009) Vascular MMP-9\/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study. J Proteome Res 8:3191\u20133197. https:\/\/doi.org\/10.1021\/pr801012x","journal-title":"J Proteome Res"},{"key":"3174_CR40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/jcbfm.2008.130","volume":"29","author":"E Cuadrado","year":"2009","unstructured":"Cuadrado E, Rosell A, Borrell-Pag\u00e8s M et al (2009) Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia. J Cereb Blood Flow Metab 29:398\u2013410. https:\/\/doi.org\/10.1038\/jcbfm.2008.130","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Pt 8","key":"3174_CR41","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/brain\/122.8.1579","volume":"122","author":"BC Kieseier","year":"1999","unstructured":"Kieseier BC, Paul R, Koedel U et al (1999) Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122(Pt 8):1579\u20131587","journal-title":"Brain"},{"key":"3174_CR42","doi-asserted-by":"publisher","first-page":"12796","DOI":"10.1038\/srep12796","volume":"5","author":"D Cui","year":"2015","unstructured":"Cui D, Arima M, Takubo K et al (2015) ADAM12 and ADAM17 are essential molecules for hypoxia-induced impairment of neural vascular barrier function. Sci Rep 5:12796. https:\/\/doi.org\/10.1038\/srep12796","journal-title":"Sci Rep"},{"key":"3174_CR43","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/nm.2451","volume":"17","author":"I Inoshima","year":"2011","unstructured":"Inoshima I, Inoshima N, Wilke GA et al (2011) A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat Med 17:1310\u20131314. https:\/\/doi.org\/10.1038\/nm.2451","journal-title":"Nat Med"},{"key":"3174_CR44","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1161\/CIRCRESAHA.108.177394","volume":"102","author":"B Ponnuchamy","year":"2008","unstructured":"Ponnuchamy B, Khalil RA (2008) Role of ADAMs in endothelial cell permeability: cadherin shedding and leukocyte rolling. Circ Res 102:1139\u20131142. https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.177394","journal-title":"Circ Res"},{"key":"3174_CR45","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1073\/pnas.48.6.1014","volume":"48","author":"J Gross","year":"1962","unstructured":"Gross J, Lapiere CM (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 48:1014\u20131022","journal-title":"Proc Natl Acad Sci USA"},{"key":"3174_CR46","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood.V96.8.2673","volume":"96","author":"PE Van den Steen","year":"2000","unstructured":"Van den Steen PE, Proost P, Wuyts A et al (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96:2673\u20132681","journal-title":"Blood"},{"key":"3174_CR47","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.289.5482.1202","volume":"289","author":"GA McQuibban","year":"2000","unstructured":"McQuibban GA, Gong JH, Tam EM et al (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289:1202\u20131206","journal-title":"Science"},{"key":"3174_CR48","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1182\/blood.V100.4.1160.h81602001160_1160_1167","volume":"100","author":"GA McQuibban","year":"2002","unstructured":"McQuibban GA, Gong J-H, Wong JP et al (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100:1160\u20131167","journal-title":"Blood"},{"key":"3174_CR49","doi-asserted-by":"publisher","first-page":"43503","DOI":"10.1074\/jbc.M107736200","volume":"276","author":"GA McQuibban","year":"2001","unstructured":"McQuibban GA, Butler GS, Gong J-H et al (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276:43503\u201343508. https:\/\/doi.org\/10.1074\/jbc.M107736200","journal-title":"J Biol Chem"},{"key":"3174_CR50","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nn1127","volume":"6","author":"K Zhang","year":"2003","unstructured":"Zhang K, McQuibban GA, Silva C et al (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 6:1064\u20131071. https:\/\/doi.org\/10.1038\/nn1127","journal-title":"Nat Neurosci"},{"key":"3174_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4049\/jimmunol.1202286","volume":"190","author":"J Song","year":"2013","unstructured":"Song J, Wu C, Zhang X, Sorokin LM (2013) In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1-induced peritonitis. J Immunol 190:401\u2013410. https:\/\/doi.org\/10.4049\/jimmunol.1202286","journal-title":"J Immunol"},{"key":"3174_CR52","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1371\/journal.pone.0000312","volume":"2","author":"AM Tester","year":"2007","unstructured":"Tester AM, Cox JH, Connor AR et al (2007) LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PLoS One 2:e312. https:\/\/doi.org\/10.1371\/journal.pone.0000312","journal-title":"PLoS One"},{"key":"3174_CR53","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1182\/blood-2012-08-451575","volume":"121","author":"PV Afonso","year":"2013","unstructured":"Afonso PV, McCann CP, Kapnick SM, Parent CA (2013) Discoidin domain receptor 2 regulates neutrophil chemotaxis in 3D collagen matrices. Blood 121:1644\u20131650. https:\/\/doi.org\/10.1182\/blood-2012-08-451575","journal-title":"Blood"},{"key":"3174_CR54","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1046\/j.1432-1033.2003.03760.x","volume":"270","author":"PE Van Den Steen","year":"2003","unstructured":"Van Den Steen PE, Wuyts A, Husson SJ et al (2003) Gelatinase B\/MMP-9 and neutrophil collagenase\/MMP-8 process the chemokines human GCP-2\/CXCL6, ENA-78\/CXCL5 and mouse GCP-2\/LIX and modulate their physiological activities. Eur J Biochem 270:3739\u20133749","journal-title":"Eur J Biochem"},{"key":"3174_CR55","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood.V93.7.2173","volume":"93","author":"MH Khandaker","year":"1999","unstructured":"Khandaker MH, Mitchell G, Xu L et al (1999) Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR55 and CXCR55 chemokine receptor expression. Blood 93:2173\u20132185","journal-title":"Blood"},{"key":"3174_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0092-8674(02)01079-6","volume":"111","author":"Q Li","year":"2002","unstructured":"Li Q, Park PW, Wilson CL, Parks WC (2002) Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111:635\u2013646","journal-title":"Cell"},{"key":"3174_CR57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/ni773","volume":"3","author":"DB Corry","year":"2002","unstructured":"Corry DB, Rishi K, Kanellis J et al (2002) Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol 3:347\u2013353. https:\/\/doi.org\/10.1038\/ni773","journal-title":"Nat Immunol"},{"key":"3174_CR58","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1096\/fj.03-1412fje","volume":"18","author":"DB Corry","year":"2004","unstructured":"Corry DB, Kiss A, Song L-Z et al (2004) Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J 18:995\u2013997. https:\/\/doi.org\/10.1096\/fj.03-1412fje","journal-title":"FASEB J"},{"key":"3174_CR59","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/356768a0","volume":"356","author":"NA Thornberry","year":"1992","unstructured":"Thornberry NA, Bull HG, Calaycay JR et al (1992) A novel heterodimeric cysteine protease is required for interleukin-1\u03b2processing in monocytes. Nature 356:768\u2013774. https:\/\/doi.org\/10.1038\/356768a0","journal-title":"Nature"},{"key":"3174_CR60","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.1073\/pnas.86.14.5227","volume":"86","author":"MJ Kostura","year":"1989","unstructured":"Kostura MJ, Tocci MJ, Limjuco G et al (1989) Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA 86:5227\u20135231","journal-title":"Proc Natl Acad Sci USA"},{"key":"3174_CR61","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.158.4.1818","volume":"158","author":"G Fantuzzi","year":"1997","unstructured":"Fantuzzi G, Ku G, Harding MW et al (1997) Response to local inflammation of IL-1 beta-converting enzyme-deficient mice. J Immunol 158:1818\u20131824","journal-title":"J Immunol"},{"key":"3174_CR62","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.4049\/jimmunol.161.7.3340","volume":"161","author":"U Sch\u00f6nbeck","year":"1998","unstructured":"Sch\u00f6nbeck U, Mach F, Libby P (1998) Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 161:3340\u20133346","journal-title":"J Immunol"},{"key":"3174_CR63","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/385733a0","volume":"385","author":"ML Moss","year":"1997","unstructured":"Moss ML, Jin S-LC, Milla ME et al (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-\u03b1. Nature 385:733\u2013736. https:\/\/doi.org\/10.1038\/385733a0","journal-title":"Nature"},{"key":"3174_CR64","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/385729a0","volume":"385","author":"RA Black","year":"1997","unstructured":"Black RA, Rauch CT, Kozlosky CJ et al (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-\u03b1 from cells. Nature 385:729\u2013733. https:\/\/doi.org\/10.1038\/385729a0","journal-title":"Nature"},{"key":"3174_CR65","doi-asserted-by":"publisher","first-page":"9462","DOI":"10.1021\/bi0260132","volume":"41","author":"MJ Mohan","year":"2002","unstructured":"Mohan MJ, Seaton T, Mitchell J et al (2002) The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Biochemistry 41:9462\u20139469","journal-title":"Biochemistry"},{"key":"3174_CR66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163\u2013176","journal-title":"Genes Dev"},{"key":"3174_CR67","doi-asserted-by":"publisher","first-page":"44061","DOI":"10.1074\/jbc.M207205200","volume":"277","author":"MA Karsdal","year":"2002","unstructured":"Karsdal MA, Larsen L, Engsig MT et al (2002) Matrix metalloproteinase-dependent activation of latent transforming growth factor-\u03b2 controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 277:44061\u201344067. https:\/\/doi.org\/10.1074\/jbc.M207205200","journal-title":"J Biol Chem"},{"key":"3174_CR68","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s002230010032","volume":"70","author":"S Maeda","year":"2002","unstructured":"Maeda S, Dean DD, Gomez R et al (2002) The first stage of transforming growth factor \u03b21 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Calcif Tissue Int 70:54\u201365. https:\/\/doi.org\/10.1007\/s002230010032","journal-title":"Calcif Tissue Int"},{"key":"3174_CR69","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","volume":"96","author":"JS Munger","year":"1999","unstructured":"Munger JS, Huang X, Kawakatsu H et al (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319\u2013328","journal-title":"Cell"},{"key":"3174_CR70","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/359693a0","volume":"359","author":"MM Shull","year":"1992","unstructured":"Shull MM, Ormsby I, Kier AB et al (1992) Targeted disruption of the mouse transforming growth factor-\u03b21 gene results in multifocal inflammatory disease. Nature 359:693\u2013699. https:\/\/doi.org\/10.1038\/359693a0","journal-title":"Nature"},{"key":"3174_CR71","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/370555a0","volume":"370","author":"AJH Gearing","year":"1994","unstructured":"Gearing AJH, Beckett P, Christodoulou M et al (1994) Processing of tumour necrosis factor-\u03b1 precursor by metalloproteinases. Nature 370:555\u2013557. https:\/\/doi.org\/10.1038\/370555a0","journal-title":"Nature"},{"key":"3174_CR72","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/0092-8674(95)90192-2","volume":"83","author":"M Grell","year":"1995","unstructured":"Grell M, Douni E, Wajant H et al (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80\u00a0kDa tumor necrosis factor receptor. Cell 83:793\u2013802","journal-title":"Cell"},{"key":"3174_CR73","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1189\/jlb.0307193","volume":"82","author":"JH Bell","year":"2007","unstructured":"Bell JH, Herrera AH, Li Y, Walcheck B (2007) Role of ADAM17 in the ectodomain shedding of TNF-and its receptors by neutrophils and macrophages. J Leukoc Biol 82:173\u2013176. https:\/\/doi.org\/10.1189\/jlb.0307193","journal-title":"J Leukoc Biol"},{"key":"3174_CR74","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","volume":"282","author":"JJ Peschon","year":"1998","unstructured":"Peschon JJ, Slack JL, Reddy P et al (1998) An essential role for ectodomain shedding in mammalian development. Science 282:1281\u20131284","journal-title":"Science"},{"key":"3174_CR75","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.4049\/jimmunol.179.5.2686","volume":"179","author":"K Horiuchi","year":"2007","unstructured":"Horiuchi K, Kimura T, Miyamoto T et al (2007) Cutting edge: TNF-alpha-converting enzyme (TACE\/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol 179:2686\u20132689","journal-title":"J Immunol"},{"key":"3174_CR76","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4049\/jimmunol.176.2.721","volume":"176","author":"DS Smookler","year":"2006","unstructured":"Smookler DS, Mohammed FF, Kassiri Z et al (2006) Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 176:721\u2013725","journal-title":"J Immunol"},{"key":"3174_CR77","doi-asserted-by":"publisher","first-page":"14804","DOI":"10.1074\/jbc.M111.229393","volume":"286","author":"C Garbers","year":"2011","unstructured":"Garbers C, J\u00e4nner N, Chalaris A et al (2011) Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding. J Biol Chem 286:14804\u201314811. https:\/\/doi.org\/10.1074\/jbc.M111.229393","journal-title":"J Biol Chem"},{"key":"3174_CR78","doi-asserted-by":"publisher","first-page":"7102","DOI":"10.4049\/jimmunol.180.11.7102","volume":"180","author":"EM Briso","year":"2008","unstructured":"Briso EM, Dienz O, Rincon M (2008) Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells. J Immunol 180:7102\u20137106","journal-title":"J Immunol"},{"key":"3174_CR79","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1582-4934.2005.tb00354.x","volume":"9","author":"DM Smalley","year":"2005","unstructured":"Smalley DM, Ley K (2005) L-selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med 9:255\u2013266","journal-title":"J Cell Mol Med"},{"key":"3174_CR80","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1182\/blood-2010-11-321406","volume":"118","author":"J Tang","year":"2011","unstructured":"Tang J, Zarbock A, Gomez I et al (2011) Adam17-dependent shedding limits early neutrophil influx but does not alter early monocyte recruitment to inflammatory sites. Blood 118:786\u2013794. https:\/\/doi.org\/10.1182\/blood-2010-11-321406","journal-title":"Blood"},{"key":"3174_CR81","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1189\/jlb.0312112","volume":"92","author":"C Long","year":"2012","unstructured":"Long C, Hosseinkhani MR, Wang Y et al (2012) ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment. J Leukoc Biol 92:667\u2013672. https:\/\/doi.org\/10.1189\/jlb.0312112","journal-title":"J Leukoc Biol"},{"key":"3174_CR82","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1083\/jcb.200307137","volume":"164","author":"U Sahin","year":"2004","unstructured":"Sahin U, Weskamp G, Kelly K et al (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164:769\u2013779. https:\/\/doi.org\/10.1083\/jcb.200307137","journal-title":"J Cell Biol"},{"key":"3174_CR83","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1084\/jem.20092366","volume":"207","author":"A Chalaris","year":"2010","unstructured":"Chalaris A, Adam N, Sina C et al (2010) Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J Exp Med 207:1617\u20131624. https:\/\/doi.org\/10.1084\/jem.20092366","journal-title":"J Exp Med"},{"key":"3174_CR84","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1097-2765(00)80417-7","volume":"5","author":"C Brou","year":"2000","unstructured":"Brou C, Logeat F, Gupta N et al (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 5:207\u2013216","journal-title":"Mol Cell"},{"key":"3174_CR85","doi-asserted-by":"publisher","first-page":"31018","DOI":"10.1074\/jbc.M109.006775","volume":"284","author":"G van Tetering","year":"2009","unstructured":"van Tetering G, van Diest P, Verlaan I et al (2009) Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J Biol Chem 284:31018\u201331027. https:\/\/doi.org\/10.1074\/jbc.M109.006775","journal-title":"J Biol Chem"},{"key":"3174_CR86","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.immuni.2012.01.005","volume":"36","author":"A Murthy","year":"2012","unstructured":"Murthy A, Shao YW, Narala SR et al (2012) Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity 36:105\u2013119. https:\/\/doi.org\/10.1016\/j.immuni.2012.01.005","journal-title":"Immunity"},{"key":"3174_CR87","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.bbamcr.2012.11.027","volume":"1833","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wu J, Newton R et al (2013) ADAM17 cleaves CD16b (Fc\u03b3RIIIb) in human neutrophils. Biochim Biophys Acta 1833:680\u2013685. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.11.027","journal-title":"Biochim Biophys Acta"},{"key":"3174_CR88","doi-asserted-by":"publisher","first-page":"39554","DOI":"10.1074\/jbc.M112.408625","volume":"287","author":"A Moncada-Pazos","year":"2012","unstructured":"Moncada-Pazos A, Obaya AJ, Llamazares M et al (2012) ADAMTS-12 metalloprotease is necessary for normal inflammatory response. J Biol Chem 287:39554\u201339563. https:\/\/doi.org\/10.1074\/jbc.M112.408625","journal-title":"J Biol Chem"},{"key":"3174_CR89","doi-asserted-by":"publisher","first-page":"16064","DOI":"10.1523\/JNEUROSCI.4158-11.2011","volume":"31","author":"M-E Tremblay","year":"2011","unstructured":"Tremblay M-E, Stevens B, Sierra A et al (2011) The role of microglia in the healthy brain. J Neurosci 31:16064\u201316069. https:\/\/doi.org\/10.1523\/JNEUROSCI.4158-11.2011","journal-title":"J Neurosci"},{"key":"3174_CR90","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","volume":"119","author":"MB Graeber","year":"2010","unstructured":"Graeber MB, Streit WJ (2010) Microglia: biology and pathology. Acta Neuropathol 119:89\u2013105. https:\/\/doi.org\/10.1007\/s00401-009-0622-0","journal-title":"Acta Neuropathol"},{"key":"3174_CR91","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"JD Cherry","year":"2014","unstructured":"Cherry JD, Olschowka JA, O\u2019Banion M (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98. https:\/\/doi.org\/10.1186\/1742-2094-11-98","journal-title":"J Neuroinflammation"},{"key":"3174_CR92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12011","volume":"39","author":"D Boche","year":"2013","unstructured":"Boche D, Perry VH, Nicoll JAR (2013) Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39:3\u201318. https:\/\/doi.org\/10.1111\/nan.12011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3174_CR93","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/glia.10108","volume":"39","author":"GA Rosenberg","year":"2002","unstructured":"Rosenberg GA (2002) Matrix metalloproteinases in neuroinflammation. Glia 39:279\u2013291. https:\/\/doi.org\/10.1002\/glia.10108","journal-title":"Glia"},{"key":"3174_CR94","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/glia.20478","volume":"55","author":"RK Nuttall","year":"2007","unstructured":"Nuttall RK, Silva C, Hader W et al (2007) Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia 55:516\u2013526. https:\/\/doi.org\/10.1002\/glia.20478","journal-title":"Glia"},{"key":"3174_CR95","doi-asserted-by":"publisher","first-page":"e42507","DOI":"10.1371\/journal.pone.0042507","volume":"7","author":"W-C Huang","year":"2012","unstructured":"Huang W-C, Sala-Newby GB, Susana A et al (2012) Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-\u03baB. PLoS One 7:e42507. https:\/\/doi.org\/10.1371\/journal.pone.0042507","journal-title":"PLoS One"},{"key":"3174_CR96","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/ijms18102135","volume":"18","author":"M Kanazawa","year":"2017","unstructured":"Kanazawa M, Ninomiya I, Hatakeyama M et al (2017) Microglia and monocytes\/macrophages polarization reveal novel therapeutic mechanism against stroke. Int J Mol Sci 18:2135. https:\/\/doi.org\/10.3390\/ijms18102135","journal-title":"Int J Mol Sci"},{"key":"3174_CR97","doi-asserted-by":"publisher","first-page":"42582","DOI":"10.1038\/srep42582","volume":"7","author":"M Kanazawa","year":"2017","unstructured":"Kanazawa M, Miura M, Toriyabe M et al (2017) Microglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats. Sci Rep 7:42582. https:\/\/doi.org\/10.1038\/srep42582","journal-title":"Sci Rep"},{"key":"3174_CR98","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1523\/JNEUROSCI.4085-05.2006","volume":"26","author":"S-R Lee","year":"2006","unstructured":"Lee S-R, Kim H-Y, Rogowska J et al (2006) Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J Neurosci 26:3491\u20133495. https:\/\/doi.org\/10.1523\/JNEUROSCI.4085-05.2006","journal-title":"J Neurosci"},{"key":"3174_CR99","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1523\/JNEUROSCI.5380-05.2006","volume":"26","author":"L Wang","year":"2006","unstructured":"Wang L, Zhang ZG, Zhang RL et al (2006) Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J Neurosci 26:5996\u20136003. https:\/\/doi.org\/10.1523\/JNEUROSCI.5380-05.2006","journal-title":"J Neurosci"},{"key":"3174_CR100","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nm1387","volume":"12","author":"B-Q Zhao","year":"2006","unstructured":"Zhao B-Q, Wang S, Kim H-Y et al (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441\u2013445. https:\/\/doi.org\/10.1038\/nm1387","journal-title":"Nat Med"},{"key":"3174_CR101","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.neuroscience.2008.06.025","volume":"158","author":"E Candelario-Jalil","year":"2009","unstructured":"Candelario-Jalil E, Yang Y, Rosenberg GA (2009) Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158:983\u2013994. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.06.025","journal-title":"Neuroscience"},{"key":"3174_CR102","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coph.2007.12.001","volume":"8","author":"A Rosell","year":"2008","unstructured":"Rosell A, Lo E (2008) Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 8:82\u201389. https:\/\/doi.org\/10.1016\/j.coph.2007.12.001","journal-title":"Curr Opin Pharmacol"},{"key":"3174_CR103","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/sj.jcbfm.9600534","volume":"28","author":"RR Sood","year":"2008","unstructured":"Sood RR, Taheri S, Candelario-Jalil E et al (2008) Early beneficial effect of matrix metalloproteinase inhibition on blood\u2014brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain. J Cereb Blood Flow Metab 28:431\u2013438. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600534","journal-title":"J Cereb Blood Flow Metab"},{"key":"3174_CR104","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-3-319-45514-3_10","volume-title":"The blood brain barrier and inflammation","author":"P Agyeman","year":"2017","unstructured":"Agyeman P, Grandgirard D, Leib SL (2017) Neuroinflammation in bacterial meningitis. The blood brain barrier and inflammation. Springer International Publishing, Cham, pp 213\u2013252"},{"key":"3174_CR105","first-page":"341","volume-title":"Infections of the central nervous system","author":"P Agyeman","year":"2014","unstructured":"Agyeman P, Grandgirard D, Leib S (2014) Pathogenesis and pathophysiology of bacterial infections. In: Scheld M, Whitley RJ, Marra CM (eds) Infections of the central nervous system. Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp 341\u2013364"},{"key":"3174_CR106","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","volume":"22","author":"D van de Beek","year":"2016","unstructured":"van de Beek D, Cabellos C, Dzupova O et al (2016) ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 22:S37\u2013S62. https:\/\/doi.org\/10.1016\/j.cmi.2016.01.007","journal-title":"Clin Microbiol Infect"},{"key":"3174_CR107","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1473-3099(02)00450-4","volume":"2","author":"U Koedel","year":"2002","unstructured":"Koedel U, Scheld WM, Pfister H-W (2002) Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2:721\u2013736","journal-title":"Lancet Infect Dis"},{"key":"3174_CR108","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","volume":"10","author":"K Edmond","year":"2010","unstructured":"Edmond K, Clark A, Korczak VS et al (2010) Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 10:317\u2013328. https:\/\/doi.org\/10.1016\/S1473-3099(10)70048-7","journal-title":"Lancet Infect Dis"},{"key":"3174_CR109","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1128\/CMR.00070-09","volume":"23","author":"MC Brouwer","year":"2010","unstructured":"Brouwer MC, Tunkel AR, van de Beek D (2010) Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 23:467\u2013492. https:\/\/doi.org\/10.1128\/CMR.00070-09","journal-title":"Clin Microbiol Rev"},{"key":"3174_CR110","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0304-3940(00)01645-1","volume":"296","author":"A Wellmer","year":"2000","unstructured":"Wellmer A, Noeske C, Gerber J et al (2000) Spatial memory and learning deficits after experimental pneumococcal meningitis in mice. Neurosci Lett 296:137\u2013140","journal-title":"Neurosci Lett"},{"key":"3174_CR111","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1086\/317921","volume":"183","author":"JM Loeffler","year":"2001","unstructured":"Loeffler JM, Ringer R, Habl\u00fctzel M et al (2001) The free radical scavenger \u03b1-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J Infect Dis 183:247\u2013252. https:\/\/doi.org\/10.1086\/317921","journal-title":"J Infect Dis"},{"key":"3174_CR112","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0166-2236(00)02024-5","volume":"25","author":"R Nau","year":"2002","unstructured":"Nau R, Br\u00fcck W (2002) Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 25:38\u201345","journal-title":"Trends Neurosci"},{"key":"3174_CR113","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1203\/01.PDR.0000079185.67878.72","volume":"54","author":"SL Leib","year":"2003","unstructured":"Leib SL, Heimgartner C, Bifrare Y-D et al (2003) Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr Res 54:353\u2013357. https:\/\/doi.org\/10.1203\/01.PDR.0000079185.67878.72","journal-title":"Pediatr Res"},{"key":"3174_CR114","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00005072-199903000-00006","volume":"58","author":"R Nau","year":"1999","unstructured":"Nau R, Soto A, Bruck W (1999) Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol 58:265\u2013274. https:\/\/doi.org\/10.1097\/00005072-199903000-00006","journal-title":"J Neuropathol Exp Neurol"},{"key":"3174_CR115","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/WCO.0b013e32833950dd","volume":"23","author":"J Gerber","year":"2010","unstructured":"Gerber J, Nau R (2010) Mechanisms of injury in bacterial meningitis. Curr Opin Neurol 23:312\u2013318. https:\/\/doi.org\/10.1097\/WCO.0b013e32833950dd","journal-title":"Curr Opin Neurol"},{"key":"3174_CR116","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/CMR.00008-11","volume":"24","author":"BB Mook-Kanamori","year":"2011","unstructured":"Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D (2011) Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev 24:557\u2013591. https:\/\/doi.org\/10.1128\/CMR.00008-11","journal-title":"Clin Microbiol Rev"},{"key":"3174_CR117","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1086\/425520","volume":"190","author":"L Mitchell","year":"2004","unstructured":"Mitchell L, Smith SH, Braun JS et al (2004) Dual phases of apoptosis in pneumococcal meningitis. J Infect Dis 190:2039\u20132046. https:\/\/doi.org\/10.1086\/425520","journal-title":"J Infect Dis"},{"key":"3174_CR118","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00401-003-0672-7","volume":"105","author":"C Gianinazzi","year":"2003","unstructured":"Gianinazzi C, Grandgirard D, Imboden H et al (2003) Caspase-3 mediates hippocampal apoptosis in pneumococcal meningitis. Acta Neuropathol 105:499\u2013507. https:\/\/doi.org\/10.1007\/s00401-003-0672-7","journal-title":"Acta Neuropathol"},{"key":"3174_CR119","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1096\/fj.03-0670fje","volume":"18","author":"AI Iliev","year":"2003","unstructured":"Iliev AI, Stringaris AK, Nau R, Neumann H (2003) Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J 18:412\u2013414. https:\/\/doi.org\/10.1096\/fj.03-0670fje","journal-title":"FASEB J"},{"key":"3174_CR120","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/13550280802093927","volume":"14","author":"CP Marques","year":"2008","unstructured":"Marques CP, Cheeran MC-J, Palmquist JM et al (2008) Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis. J Neurovirol 14:229\u2013238. https:\/\/doi.org\/10.1080\/13550280802093927","journal-title":"J Neurovirol"},{"key":"3174_CR121","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.heares.2017.04.012","volume":"350","author":"M Perny","year":"2017","unstructured":"Perny M, Solyga M, Grandgirard D et al (2017) Streptococcus pneumoniae-induced ototoxicity in organ of Corti explant cultures. Hear Res 350:100\u2013109. https:\/\/doi.org\/10.1016\/j.heares.2017.04.012","journal-title":"Hear Res"},{"key":"3174_CR122","doi-asserted-by":"publisher","first-page":"7740","DOI":"10.1523\/JNEUROSCI.0554-16.2016","volume":"36","author":"M Perny","year":"2016","unstructured":"Perny M, Roccio M, Grandgirard D et al (2016) The severity of infection determines the localization of damage and extent of sensorineural hearing loss in experimental pneumococcal meningitis. J Neurosci 36:7740\u20137749. https:\/\/doi.org\/10.1523\/JNEUROSCI.0554-16.2016","journal-title":"J Neurosci"},{"key":"3174_CR123","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1750-3639.2003.tb00012.x","volume":"13","author":"M Klein","year":"2003","unstructured":"Klein M, Koedel U, Pfister H-W, Kastenbauer S (2003) Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis. Brain Pathol 13:123\u2013132. https:\/\/doi.org\/10.1111\/j.1750-3639.2003.tb00012.x","journal-title":"Brain Pathol"},{"key":"3174_CR124","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1056\/NEJMoa040845","volume":"351","author":"D van de Beek","year":"2004","unstructured":"van de Beek D, de Gans J, Spanjaard L et al (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351:1849\u20131859. https:\/\/doi.org\/10.1056\/NEJMoa040845","journal-title":"N Engl J Med"},{"key":"3174_CR125","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/INF.0b013e3181ef25f7","volume":"30","author":"A Chandran","year":"2011","unstructured":"Chandran A, Herbert H, Misurski D, Santosham M (2011) Long-term sequelae of childhood bacterial meningitis: an underappreciated problem. Pediatr Infect Dis J 30:3\u20136. https:\/\/doi.org\/10.1097\/INF.0b013e3181ef25f7","journal-title":"Pediatr Infect Dis J"},{"key":"3174_CR126","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1128\/iai.64.12.4883-4890.1996","volume":"64","author":"AM van Furth","year":"1996","unstructured":"van Furth AM, Roord JJ, van Furth R (1996) Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun 64:4883\u20134890","journal-title":"Infect Immun"},{"key":"3174_CR127","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/brain\/124.9.1734","volume":"124","author":"SL Leib","year":"2001","unstructured":"Leib SL, Clements JM, Lindberg RLP et al (2001) Inhibition of matrix metalloproteinases and tumour necrosis factor \u03b1 converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124:1734\u20131742. https:\/\/doi.org\/10.1093\/brain\/124.9.1734","journal-title":"Brain"},{"key":"3174_CR128","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1128\/IAI.68.2.615-620.2000","volume":"68","author":"SL Leib","year":"2000","unstructured":"Leib SL, Leppert D, Clements J, T\u00e4uber MG (2000) Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 68:615\u2013620","journal-title":"Infect Immun"},{"key":"3174_CR129","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","volume":"8","author":"GA Rosenberg","year":"2009","unstructured":"Rosenberg GA (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8:205\u2013216. https:\/\/doi.org\/10.1016\/S1474-4422(09)70016-X","journal-title":"Lancet Neurol"},{"key":"3174_CR130","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0165-0173(01)00101-1","volume":"36","author":"D Leppert","year":"2001","unstructured":"Leppert D, Lindberg RLP, Kappos L, Leib SL (2001) Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev 36:249\u2013257. https:\/\/doi.org\/10.1016\/S0165-0173(01)00101-1","journal-title":"Brain Res Rev"},{"key":"3174_CR131","doi-asserted-by":"publisher","first-page":"e1000874","DOI":"10.1371\/journal.ppat.1000874","volume":"6","author":"A Schubert-Unkmeir","year":"2010","unstructured":"Schubert-Unkmeir A, Konrad C, Slanina H et al (2010) Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog 6:e1000874. https:\/\/doi.org\/10.1371\/journal.ppat.1000874","journal-title":"PLoS Pathog"},{"key":"3174_CR132","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jneuroim.2004.01.026","volume":"151","author":"D Meli","year":"2004","unstructured":"Meli D, Loeffler J, Baumann P et al (2004) In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-\u03b1 converting enzyme attenuates seizures and injury of the cerebral cortex. J Neuroimmunol 151:6\u201311. https:\/\/doi.org\/10.1016\/j.jneuroim.2004.01.026","journal-title":"J Neuroimmunol"},{"key":"3174_CR133","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0165-5728(96)00179-8","volume":"72","author":"S Chandler","year":"1997","unstructured":"Chandler S, Miller KM, Clements JM et al (1997) Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 72:155\u2013161","journal-title":"J Neuroimmunol"},{"key":"3174_CR134","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","volume":"21","author":"M Asahi","year":"2001","unstructured":"Asahi M, Wang X, Mori T et al (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21:7724\u20137732","journal-title":"J Neurosci"},{"key":"3174_CR135","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3940(02)01406-4","volume":"338","author":"T B\u00f6ttcher","year":"2003","unstructured":"B\u00f6ttcher T, Spreer A, Azeh I et al (2003) Matrix metalloproteinase-9 deficiency impairs host defense mechanisms against Streptococcus pneumoniae in a mouse model of bacterial meningitis. Neurosci Lett 338:201\u2013204. https:\/\/doi.org\/10.1016\/S0304-3940(02)01406-4","journal-title":"Neurosci Lett"},{"key":"3174_CR136","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1523\/JNEUROSCI.1563-05.2005","volume":"25","author":"Z Gu","year":"2005","unstructured":"Gu Z, Cui J, Brown S et al (2005) A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25:6401\u20136408. https:\/\/doi.org\/10.1523\/JNEUROSCI.1563-05.2005","journal-title":"J Neurosci"},{"key":"3174_CR137","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10072-009-0192-x","volume":"31","author":"Z Guo","year":"2010","unstructured":"Guo Z, Sun X, He Z et al (2010) Role of matrix metalloproteinase-9 in apoptosis of hippocampal neurons in rats during early brain injury after subarachnoid hemorrhage. Neurol Sci 31:143\u2013149. https:\/\/doi.org\/10.1007\/s10072-009-0192-x","journal-title":"Neurol Sci"},{"key":"3174_CR138","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1365-2990.2006.00729.x","volume":"32","author":"RLP Lindberg","year":"2006","unstructured":"Lindberg RLP, Sorsa T, Tervahartiala T et al (2006) Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8\/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children. Neuropathol Appl Neurobiol 32:304\u2013317. https:\/\/doi.org\/10.1111\/j.1365-2990.2006.00729.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3174_CR139","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0022-510X(02)00317-9","volume":"206","author":"S Shapiro","year":"2003","unstructured":"Shapiro S, Miller A, Lahat N et al (2003) Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis. J Neurol Sci 206:43\u201348. https:\/\/doi.org\/10.1016\/S0022-510X(02)00317-9","journal-title":"J Neurol Sci"},{"key":"3174_CR140","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0165-5728(00)00339-8","volume":"110","author":"M Yushchenko","year":"2000","unstructured":"Yushchenko M, Weber F, M\u00e4der M et al (2000) Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count. J Neuroimmunol 110:244\u2013251. https:\/\/doi.org\/10.1016\/S0165-5728(00)00339-8","journal-title":"J Neuroimmunol"},{"key":"3174_CR141","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1212\/WNL.0b013e31820b7600","volume":"76","author":"JA Green","year":"2011","unstructured":"Green JA, Thi Hong Chau T, Farrar JJ et al (2011) CNS infection, CSF matrix metalloproteinase concentrations, and clinical\/laboratory features. Neurology 76:577\u2013579. https:\/\/doi.org\/10.1212\/WNL.0b013e31820b7600","journal-title":"Neurology"},{"key":"3174_CR142","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1469-0691.2010.03393.x","volume":"17","author":"H-C Tsai","year":"2011","unstructured":"Tsai H-C, Shi M-H, Lee SS-J et al (2011) Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis. Clin Microbiol Infect 17:780\u2013784. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03393.x","journal-title":"Clin Microbiol Infect"},{"key":"3174_CR143","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/J.BBACLI.2014.06.001","volume":"1","author":"MM Koopmans","year":"2014","unstructured":"Koopmans MM, Brouwer MC, Geldhoff M et al (2014) Cerebrospinal fluid inflammatory markers in patients with Listeria monocytogenes meningitis. BBA Clin 1:44\u201351. https:\/\/doi.org\/10.1016\/J.BBACLI.2014.06.001","journal-title":"BBA Clin"},{"key":"3174_CR144","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1128\/JCM.00714-15","volume":"53","author":"I Roine","year":"2015","unstructured":"Roine I, Pelkonen T, Lauhio A et al (2015) Changes in MMP-9 and TIMP-1 concentrations in cerebrospinal fluid after 1 week of treatment of childhood bacterial meningitis. J Clin Microbiol 53:2340\u20132342. https:\/\/doi.org\/10.1128\/JCM.00714-15","journal-title":"J Clin Microbiol"},{"key":"3174_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/312476","volume":"2013","author":"D Grandgirard","year":"2013","unstructured":"Grandgirard D, G\u00e4umann R, Coulibaly B et al (2013) The causative pathogen determines the inflammatory profile in cerebrospinal fluid and outcome in patients with bacterial meningitis. Mediat Inflamm 2013:1\u201312. https:\/\/doi.org\/10.1155\/2013\/312476","journal-title":"Mediat Inflamm"},{"key":"3174_CR146","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/iep.12191","volume":"97","author":"S Majeed","year":"2016","unstructured":"Majeed S, Radotra BD, Sharma S (2016) Adjunctive role of MMP-9 inhibition along with conventional anti-tubercular drugs against experimental tuberculous meningitis. Int J Exp Pathol 97:230\u2013237. https:\/\/doi.org\/10.1111\/iep.12191","journal-title":"Int J Exp Pathol"},{"key":"3174_CR147","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2004.02.008","volume":"220","author":"KY Lee","year":"2004","unstructured":"Lee KY, Kim EH, Yang WS et al (2004) Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis. J Neurol Sci 220:73\u201378. https:\/\/doi.org\/10.1016\/j.jns.2004.02.008","journal-title":"J Neurol Sci"},{"key":"3174_CR148","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1186\/s12879-016-1953-9","volume":"16","author":"S Majeed","year":"2016","unstructured":"Majeed S, Singh P, Sharma N, Sharma S (2016) Title: role of matrix metalloproteinase-9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease. BMC Infect Dis 16:722. https:\/\/doi.org\/10.1186\/s12879-016-1953-9","journal-title":"BMC Infect Dis"},{"key":"3174_CR149","doi-asserted-by":"publisher","first-page":"e7277","DOI":"10.1371\/journal.pone.0007277","volume":"4","author":"JA Green","year":"2009","unstructured":"Green JA, Tran CTH, Farrar JJ et al (2009) Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS One 4:e7277. https:\/\/doi.org\/10.1371\/journal.pone.0007277","journal-title":"PLoS One"},{"key":"3174_CR150","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1056\/NEJMoa040573","volume":"351","author":"GE Thwaites","year":"2004","unstructured":"Thwaites GE, Bang ND, Dung NH et al (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351:1741\u20131751. https:\/\/doi.org\/10.1056\/NEJMoa040573","journal-title":"N Engl J Med"},{"key":"3174_CR151","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.tim.2012.03.009","volume":"20","author":"KR Spindler","year":"2012","unstructured":"Spindler KR, Hsu T-H (2012) Viral disruption of the blood-brain barrier. Trends Microbiol 20:282\u2013290. https:\/\/doi.org\/10.1016\/j.tim.2012.03.009","journal-title":"Trends Microbiol"},{"key":"3174_CR152","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0165-5728(97)00247-6","volume":"84","author":"SA Kolb","year":"1998","unstructured":"Kolb SA, Lahrtz F, Paul R et al (1998) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol 84:143\u2013150","journal-title":"J Neuroimmunol"},{"key":"3174_CR153","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/j.1476-5381.2010.00982.x","volume":"161","author":"W-H Tung","year":"2010","unstructured":"Tung W-H, Tsai H-W, Lee I-T et al (2010) Japanese encephalitis virus induces matrix metalloproteinase-9 in rat brain astrocytes via NF-\u03baB signalling dependent on MAPKs and reactive oxygen species. Br J Pharmacol 161:1566\u20131583. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00982.x","journal-title":"Br J Pharmacol"},{"key":"3174_CR154","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000335182","volume":"19","author":"V Shukla","year":"2012","unstructured":"Shukla V, Kumar Shakya A, Dhole TN, Misra UK (2012) Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB\/c mouse brain challenged with Japanese encephalitis virus. NeuroImmunoModulation 19:241\u2013254. https:\/\/doi.org\/10.1159\/000335182","journal-title":"NeuroImmunoModulation"},{"key":"3174_CR155","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainres.2006.09.093","volume":"1125","author":"J Sellner","year":"2006","unstructured":"Sellner J, Simon F, Meyding-Lamade U, Leib SL (2006) Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation. Brain Res 1125:155\u2013162. https:\/\/doi.org\/10.1016\/j.brainres.2006.09.093","journal-title":"Brain Res"},{"key":"3174_CR156","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.virol.2009.10.036","volume":"397","author":"S Verma","year":"2010","unstructured":"Verma S, Kumar M, Gurjav U et al (2010) Reversal of West Nile virus-induced blood\u2013brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology 397:130\u2013138. https:\/\/doi.org\/10.1016\/j.virol.2009.10.036","journal-title":"Virology"},{"key":"3174_CR157","doi-asserted-by":"publisher","first-page":"8978","DOI":"10.1128\/JVI.00314-08","volume":"82","author":"P Wang","year":"2008","unstructured":"Wang P, Dai J, Bai F et al (2008) Matrix metalloproteinase 9 facilitates West Nile Virus entry into the brain. J Virol 82:8978\u20138985. https:\/\/doi.org\/10.1128\/JVI.00314-08","journal-title":"J Virol"},{"key":"3174_CR158","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","volume":"26","author":"EA Eugenin","year":"2006","unstructured":"Eugenin EA, Osiecki K, Lopez L et al (2006) CCL2\/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 26:1098\u20131106. https:\/\/doi.org\/10.1523\/JNEUROSCI.3863-05.2006","journal-title":"J Neurosci"},{"key":"3174_CR159","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1097\/NEN.0b013e3181e8c96f","volume":"69","author":"J-P Louboutin","year":"2010","unstructured":"Louboutin J-P, Agrawal L, Reyes BAS et al (2010) HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J Neuropathol Exp Neurol 69:801\u2013816. https:\/\/doi.org\/10.1097\/NEN.0b013e3181e8c96f","journal-title":"J Neuropathol Exp Neurol"},{"key":"3174_CR160","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0","volume":"46","author":"K Conant","year":"1999","unstructured":"Conant K, McArthur JC, Griffin DE et al (1999) Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 46:391\u2013398","journal-title":"Ann Neurol"},{"key":"3174_CR161","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/13550280009013159","volume":"6","author":"GM Liuzzi","year":"2000","unstructured":"Liuzzi GM, Mastroianni CM, Santacroce MP et al (2000) Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J Neurovirol 6:156\u2013163","journal-title":"J Neurovirol"},{"key":"3174_CR162","doi-asserted-by":"publisher","first-page":"e00079-16","DOI":"10.1128\/mSphere.00079-16","volume":"1","author":"N Tirumuru","year":"2016","unstructured":"Tirumuru N, Pretto CD, Castro Jorge LA, Spindler KR (2016) Mouse adenovirus type 1 early region 1A effects on the blood-brain barrier. mSphere 1:e00079-16. https:\/\/doi.org\/10.1128\/mSphere.00079-16","journal-title":"mSphere"},{"key":"3174_CR163","doi-asserted-by":"publisher","first-page":"e01412-16","DOI":"10.1128\/JVI.01412-16","volume":"91","author":"SL Ashley","year":"2017","unstructured":"Ashley SL, Pretto CD, Stier MT et al (2017) Matrix metalloproteinase activity in infections by an encephalitic virus, mouse adenovirus type 1. J Virol 91:e01412-16. https:\/\/doi.org\/10.1128\/JVI.01412-16","journal-title":"J Virol"},{"key":"3174_CR164","doi-asserted-by":"publisher","first-page":"9398","DOI":"10.1128\/JVI.00954-09","volume":"83","author":"LE Gralinski","year":"2009","unstructured":"Gralinski LE, Ashley SL, Dixon SD, Spindler KR (2009) Mouse adenovirus type 1-induced breakdown of the blood-brain barrier. J Virol 83:9398\u20139410. https:\/\/doi.org\/10.1128\/JVI.00954-09","journal-title":"J Virol"},{"key":"3174_CR165","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1128\/JVI.79.8.4764-4773.2005","volume":"79","author":"J Zhou","year":"2005","unstructured":"Zhou J, Marten NW, Bergmann CC et al (2005) Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. J Virol 79:4764\u20134773. https:\/\/doi.org\/10.1128\/JVI.79.8.4764-4773.2005","journal-title":"J Virol"},{"key":"3174_CR166","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1128\/JVI.76.15.7374-7384.2002","volume":"76","author":"J Zhou","year":"2002","unstructured":"Zhou J, Stohlman SA, Atkinson R et al (2002) Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infection. J Virol 76:7374\u20137384","journal-title":"J Virol"},{"key":"3174_CR167","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1128\/IAI.00073-14","volume":"82","author":"FD Liechti","year":"2014","unstructured":"Liechti FD, Grandgirard D, Leppert D, Leib SL (2014) Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis. Infect Immun 82:1710\u20131718. https:\/\/doi.org\/10.1128\/IAI.00073-14","journal-title":"Infect Immun"},{"key":"3174_CR168","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12974-015-0257-0","volume":"12","author":"FD Liechti","year":"2015","unstructured":"Liechti FD, B\u00e4chtold F, Grandgirard D et al (2015) The matrix metalloproteinase inhibitor RS-130830 attenuates brain injury in experimental pneumococcal meningitis. J Neuroinflamm 12:43. https:\/\/doi.org\/10.1186\/s12974-015-0257-0","journal-title":"J Neuroinflamm"},{"key":"3174_CR169","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12879-014-0726-6","volume":"14","author":"S Ricci","year":"2014","unstructured":"Ricci S, Grandgirard D, Wenzel M et al (2014) Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis. BMC Infect Dis 14:726. https:\/\/doi.org\/10.1186\/s12879-014-0726-6","journal-title":"BMC Infect Dis"},{"key":"3174_CR170","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2334-7-25","volume":"7","author":"H Echchannaoui","year":"2007","unstructured":"Echchannaoui H, Leib SL, Neumann U, Landmann RM (2007) Adjuvant TACE inhibitor treatment improves the outcome of TLR2\u2212\/\u2212-mice with experimental pneumococcal meningitis. BMC Infect Dis 7:25. https:\/\/doi.org\/10.1186\/1471-2334-7-25","journal-title":"BMC Infect Dis"},{"key":"3174_CR171","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.brainres.2006.11.041","volume":"1133","author":"GA Rosenberg","year":"2007","unstructured":"Rosenberg GA, Estrada EY, Mobashery S (2007) Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood\u2013brain barrier opening in rodents: differences in response based on strains and solvents. Brain Res 1133:186\u2013192. https:\/\/doi.org\/10.1016\/j.brainres.2006.11.041","journal-title":"Brain Res"},{"key":"3174_CR172","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/ana.410440404","volume":"44","author":"R Paul","year":"1998","unstructured":"Paul R, Lorenzl S, Koedel U et al (1998) Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 44:592\u2013600. https:\/\/doi.org\/10.1002\/ana.410440404","journal-title":"Ann Neurol"},{"key":"3174_CR173","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1128\/IAI.01949-05","volume":"74","author":"DN Meli","year":"2006","unstructured":"Meli DN, Coimbra RS, Erhart DG et al (2006) Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect Immun 74:3890\u20133896. https:\/\/doi.org\/10.1128\/IAI.01949-05","journal-title":"Infect Immun"},{"key":"3174_CR174","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12974-018-1272-8","volume":"15","author":"L Muri","year":"2018","unstructured":"Muri L, Grandgirard D, Buri M et al (2018) Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis. J Neuroinflamm 15:233. https:\/\/doi.org\/10.1186\/s12974-018-1272-8","journal-title":"J Neuroinflamm"},{"key":"3174_CR175","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00401-007-0304-8","volume":"114","author":"D Grandgirard","year":"2007","unstructured":"Grandgirard D, Steiner O, T\u00e4uber MG, Leib SL (2007) An infant mouse model of brain damage in pneumococcal meningitis. Acta Neuropathol 114:609\u2013617. https:\/\/doi.org\/10.1007\/s00401-007-0304-8","journal-title":"Acta Neuropathol"},{"key":"3174_CR176","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hipo.10142","volume":"13","author":"Y-D Bifrare","year":"2003","unstructured":"Bifrare Y-D, Gianinazzi C, Imboden H et al (2003) Bacterial meningitis causes two distinct forms of cellular damage in the hippocampal dentate gyrus in infant rats. Hippocampus 13:481\u2013488. https:\/\/doi.org\/10.1002\/hipo.10142","journal-title":"Hippocampus"},{"key":"3174_CR177","doi-asserted-by":"crossref","first-page":"489","DOI":"10.55782\/ane-2014-2011","volume":"74","author":"X Liu","year":"2014","unstructured":"Liu X, Han Q (2014) Efficacy of GM6001 as an adjuvant to ceftriaxone in a neonatal rat model of Streptococcus pneumoniae meningitis. Acta Neurobiol Exp (Wars) 74:489\u2013496","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"3174_CR178","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1535370213508354","volume":"239","author":"T Barichello","year":"2014","unstructured":"Barichello T, Generoso JS, Michelon CM et al (2014) Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats. Exp Biol Med (Maywood) 239:225\u2013231. https:\/\/doi.org\/10.1177\/1535370213508354","journal-title":"Exp Biol Med (Maywood)"},{"key":"3174_CR179","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/J.NBD.2004.01.013","volume":"16","author":"J Gerber","year":"2004","unstructured":"Gerber J, B\u00f6ttcher T, Hahn M et al (2004) Increased mortality and spatial memory deficits in TNF-\u03b1-deficient mice in ceftriaxone-treated experimental pneumococcal meningitis. Neurobiol Dis 16:133\u2013138. https:\/\/doi.org\/10.1016\/J.NBD.2004.01.013","journal-title":"Neurobiol Dis"},{"key":"3174_CR180","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J et al (2018) Multiple sclerosis. Lancet 391:1622\u20131636. https:\/\/doi.org\/10.1016\/S0140-6736(18)30481-1","journal-title":"Lancet"},{"key":"3174_CR181","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13819","author":"R Dobson","year":"2018","unstructured":"Dobson R, Giovannoni G (2018) Multiple sclerosis\u2014a review. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.13819","journal-title":"Eur J Neurol"},{"key":"3174_CR182","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti CF, Stadelmann C et al (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705\u20132712. https:\/\/doi.org\/10.1093\/brain\/awh641","journal-title":"Brain"},{"key":"3174_CR183","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S1474-4422(18)30245-X","volume":"17","author":"BD Trapp","year":"2018","unstructured":"Trapp BD, Vignos M, Dudman J et al (2018) Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study. Lancet Neurol 17:870\u2013884. https:\/\/doi.org\/10.1016\/S1474-4422(18)30245-X","journal-title":"Lancet Neurol"},{"key":"3174_CR184","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25119","volume":"83","author":"AL Greenfield","year":"2018","unstructured":"Greenfield AL, Hauser SL (2018) B-cell therapy for multiple sclerosis: entering an era. Ann Neurol 83:13\u201326. https:\/\/doi.org\/10.1002\/ana.25119","journal-title":"Ann Neurol"},{"key":"3174_CR185","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/WNL.53.7.1397","volume":"53","author":"E Waubant","year":"1999","unstructured":"Waubant E, Goodkin DE, Gee L et al (1999) Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology 53:1397\u20131401","journal-title":"Neurology"},{"key":"3174_CR186","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1365-2990.1997.tb01315.x","volume":"23","author":"DC Anthony","year":"1997","unstructured":"Anthony DC, Ferguson B, Matyzak MK et al (1997) Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 23:406\u2013415","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3174_CR187","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s004010050754","volume":"94","author":"JA Cossins","year":"1997","unstructured":"Cossins JA, Clements JM, Ford J et al (1997) Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 94:590\u2013598","journal-title":"Acta Neuropathol"},{"key":"3174_CR188","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00005072-199603000-00005","volume":"55","author":"A Maeda","year":"1996","unstructured":"Maeda A, Sobel RA (1996) Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 55:300\u2013309","journal-title":"J Neuropathol Exp Neurol"},{"key":"3174_CR189","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/brain\/124.9.1743","volume":"124","author":"RL Lindberg","year":"2001","unstructured":"Lindberg RL, De Groot CJ, Montagne L et al (2001) The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain 124:1743\u20131753","journal-title":"Brain"},{"issue":"Pt 1","key":"3174_CR190","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/brain\/121.1.159","volume":"121","author":"BC Kieseier","year":"1998","unstructured":"Kieseier BC, Kiefer R, Clements JM et al (1998) Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain 121(Pt 1):159\u2013166","journal-title":"Brain"},{"key":"3174_CR191","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1172\/JCI6886","volume":"104","author":"B Dubois","year":"1999","unstructured":"Dubois B, Masure S, Hurtenbach U et al (1999) Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 104:1507\u20131515. https:\/\/doi.org\/10.1172\/JCI6886","journal-title":"J Clin Invest"},{"key":"3174_CR192","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0165-5728(98)00046-0","volume":"87","author":"DC Anthony","year":"1998","unstructured":"Anthony DC, Miller KM, Fearn S et al (1998) Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol 87:62\u201372","journal-title":"J Neuroimmunol"},{"key":"3174_CR193","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1093\/brain\/124.11.2203","volume":"124","author":"TA Newman","year":"2001","unstructured":"Newman TA, Woolley ST, Hughes PM et al (2001) T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases. Brain 124:2203\u20132214. https:\/\/doi.org\/10.1093\/brain\/124.11.2203","journal-title":"Brain"},{"key":"3174_CR194","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1177\/1352458517726592","volume":"23","author":"F Sellebjerg","year":"2017","unstructured":"Sellebjerg F, B\u00f6rnsen L, Ammitzb\u00f8ll C et al (2017) Defining active progressive multiple sclerosis. Mult Scler J 23:1727\u20131735. https:\/\/doi.org\/10.1177\/1352458517726592","journal-title":"Mult Scler J"},{"issue":"Pt 12","key":"3174_CR195","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1093\/brain\/121.12.2327","volume":"121","author":"D Leppert","year":"1998","unstructured":"Leppert D, Ford J, Stabler G et al (1998) Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121(Pt 12):2327\u20132334","journal-title":"Brain"},{"key":"3174_CR196","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0165-5728(92)90192-N","volume":"41","author":"K Gijbels","year":"1992","unstructured":"Gijbels K, Masure S, Carton H, Opdenakker G (1992) Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 41:29\u201334","journal-title":"J Neuroimmunol"},{"issue":"Pt 2","key":"3174_CR197","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/brain\/122.2.191","volume":"122","author":"MA Lee","year":"1999","unstructured":"Lee MA, Palace J, Stabler G et al (1999) Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain 122(Pt 2):191\u2013197","journal-title":"Brain"},{"key":"3174_CR198","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1212\/WNL.60.1.52","volume":"60","author":"E Waubant","year":"2003","unstructured":"Waubant E, Goodkin D, Bostrom A et al (2003) IFNbeta lowers MMP-9\/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology 60:52\u201357","journal-title":"Neurology"},{"key":"3174_CR199","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1212\/WNL.46.6.1626","volume":"46","author":"GA Rosenberg","year":"1996","unstructured":"Rosenberg GA, Dencoff JE, Correa N et al (1996) Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46:1626\u20131632","journal-title":"Neurology"},{"key":"3174_CR200","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/brain\/awh028","volume":"127","author":"F Gilli","year":"2004","unstructured":"Gilli F, Bertolotto A, Sala A et al (2004) Neutralizing antibodies against IFN- in multiple sclerosis: antagonization of IFN- mediated suppression of MMPs. Brain 127:259\u2013268. https:\/\/doi.org\/10.1093\/brain\/awh028","journal-title":"Brain"},{"key":"3174_CR201","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1093\/brain\/awg285","volume":"126","author":"A Bar-Or","year":"2003","unstructured":"Bar-Or A, Nuttall RK, Duddy M et al (2003) Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 126:2738\u20132749. https:\/\/doi.org\/10.1093\/brain\/awg285","journal-title":"Brain"},{"key":"3174_CR202","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1006\/jaut.2001.0505","volume":"16","author":"M Kouwenhoven","year":"2001","unstructured":"Kouwenhoven M, \u00d6zenci V, Gomes A et al (2001) Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J Autoimmun 16:463\u2013470. https:\/\/doi.org\/10.1006\/jaut.2001.0505","journal-title":"J Autoimmun"},{"key":"3174_CR203","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1523\/JNEUROSCI.19-19-08464.1999","volume":"19","author":"LY Oh","year":"1999","unstructured":"Oh LY, Larsen PH, Krekoski CA et al (1999) Matrix metalloproteinase-9\/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19:8464\u20138475","journal-title":"J Neurosci"},{"key":"3174_CR204","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/glia.23328","volume":"66","author":"P Wang","year":"2018","unstructured":"Wang P, Gorter RP, de Jonge JC et al (2018) MMP7 cleaves remyelination-impairing fibronectin aggregates and its expression is reduced in chronic multiple sclerosis lesions. Glia 66:1625\u20131643. https:\/\/doi.org\/10.1002\/glia.23328","journal-title":"Glia"},{"key":"3174_CR205","doi-asserted-by":"publisher","first-page":"eaan3181","DOI":"10.1126\/scisignal.aan3181","volume":"10","author":"ML Dear","year":"2017","unstructured":"Dear ML, Shilts J, Broadie K (2017) Neuronal activity drives FMRP- and HSPG-dependent matrix metalloproteinase function required for rapid synaptogenesis. Sci Signal 10:eaan3181. https:\/\/doi.org\/10.1126\/scisignal.aan3181","journal-title":"Sci Signal"},{"key":"3174_CR206","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fncel.2015.00280","volume":"9","author":"SM Reinhard","year":"2015","unstructured":"Reinhard SM, Razak K, Ethell IM (2015) A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders. Front Cell Neurosci 9:280. https:\/\/doi.org\/10.3389\/fncel.2015.00280","journal-title":"Front Cell Neurosci"},{"key":"3174_CR207","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1212\/WNL.0000000000000361","volume":"82","author":"J Romme Christensen","year":"2014","unstructured":"Romme Christensen J, Ratzer R, Bornsen L et al (2014) Natalizumab in progressive MS: results of an open-label, phase 2A, proof-of-concept trial. Neurology 82:1499\u20131507. https:\/\/doi.org\/10.1212\/WNL.0000000000000361","journal-title":"Neurology"},{"key":"3174_CR208","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ana.410400607","volume":"40","author":"O St\u00fcve","year":"1996","unstructured":"St\u00fcve O, Dooley NP, Uhm JH et al (1996) Interferon \u03b2-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 40:853\u2013863. https:\/\/doi.org\/10.1002\/ana.410400607","journal-title":"Ann Neurol"},{"key":"3174_CR209","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/ana.410400606","volume":"40","author":"D Leppert","year":"1996","unstructured":"Leppert D, Waubant E, B\u00fcrk MR et al (1996) Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann Neurol 40:846\u2013852. https:\/\/doi.org\/10.1002\/ana.410400606","journal-title":"Ann Neurol"},{"key":"3174_CR210","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-5728(96)00210-X","volume":"74","author":"JM Clements","year":"1997","unstructured":"Clements JM, Cossins JA, Wells GM et al (1997) Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J Neuroimmunol 74:85\u201394","journal-title":"J Neuroimmunol"},{"key":"3174_CR211","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF01796266","volume":"44","author":"AK Hewson","year":"1995","unstructured":"Hewson AK, Smith T, Leonard JP, Cuzner ML (1995) Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm Res 44:345\u2013349","journal-title":"Inflamm Res"},{"key":"3174_CR212","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1172\/JCI117578","volume":"94","author":"K Gijbels","year":"1994","unstructured":"Gijbels K, Galardy RE, Steinman L (1994) Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 94:2177\u20132182. https:\/\/doi.org\/10.1172\/JCI117578","journal-title":"J Clin Invest"},{"key":"3174_CR213","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.4049\/jimmunol.154.9.4379","volume":"154","author":"D Leppert","year":"1995","unstructured":"Leppert D, Waubant E, Galardy R et al (1995) T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154:4379\u20134389","journal-title":"J Immunol"},{"issue":"Suppl 2","key":"3174_CR214","doi-asserted-by":"publisher","first-page":"ii43","DOI":"10.1136\/ARD.61.SUPPL_2.II43","volume":"61","author":"E Keystone","year":"2002","unstructured":"Keystone E (2002) Treatments no longer in development for rheumatoid arthritis. Ann Rheum Dis 61(Suppl 2):ii43\u2013ii45. https:\/\/doi.org\/10.1136\/ARD.61.SUPPL_2.II43","journal-title":"Ann Rheum Dis"},{"key":"3174_CR215","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1177\/1352458509106779","volume":"15","author":"L Metz","year":"2009","unstructured":"Metz L, Li D, Traboulsee A et al (2009) Glatiramer acetate in combination with minocycline in patients with relapsing\u2014remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial. Mult Scler J 15:1183\u20131194. https:\/\/doi.org\/10.1177\/1352458509106779","journal-title":"Mult Scler J"},{"key":"3174_CR216","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ana.20111","volume":"55","author":"LM Metz","year":"2004","unstructured":"Metz LM, Zhang Y, Yeung M et al (2004) Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 55:756. https:\/\/doi.org\/10.1002\/ana.20111","journal-title":"Ann Neurol"},{"key":"3174_CR217","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa1608889","volume":"376","author":"LM Metz","year":"2017","unstructured":"Metz LM, Li DKB, Traboulsee AL et al (2017) Trial of minocycline in a clinically isolated syndrome of multiple sclerosis. N Engl J Med 376:2122\u20132133. https:\/\/doi.org\/10.1056\/NEJMoa1608889","journal-title":"N Engl J Med"},{"key":"3174_CR218","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.4049\/jimmunol.1600436","volume":"197","author":"JN Hahn","year":"2016","unstructured":"Hahn JN, Kaushik DK, Mishra MK et al (2016) Impact of minocycline on extracellular matrix metalloproteinase inducer, a factor implicated in multiple sclerosis immunopathogenesis. J Immunol 197:3850\u20133860. https:\/\/doi.org\/10.4049\/jimmunol.1600436","journal-title":"J Immunol"},{"key":"3174_CR219","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/rheumatology\/40.5.537","volume":"40","author":"FJ Hemmings","year":"2001","unstructured":"Hemmings FJ, Farhan M, Rowland J et al (2001) Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis. Rheumatology (Oxford) 40:537\u2013543","journal-title":"Rheumatology (Oxford)"},{"key":"3174_CR220","unstructured":"European Medicines Agency (2015) Guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis. Committee for medicinal products for human use (CHMP). EMA\/CHMP\/771815\/2011, Rev 2. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2015\/03\/WC500185161.pdf. Accessed 4 June 2019"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-019-03174-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:59:27Z","timestamp":1744153167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-019-03174-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":220,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019,8,1]]}},"alternative-id":["3174"],"URL":"https:\/\/doi.org\/10.1007\/s00018-019-03174-6","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"23 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}